Filter
659
Text search:
pharmaceutical
industry
Featured
Recommendations
48
New Publications
160
Language
Document type
No document type
307
Studies & Reports
160
Guidelines
104
Strategic & Response Plan
38
Manuals
26
Fact sheets
8
Situation Updates
7
Training Material
2
Resource Platforms
2
Infographics
2
Online Courses
2
Brochures
1
Countries / Regions
India
31
Kenya
30
Global
30
South Africa
21
Ethiopia
18
Sierra Leone
13
Uganda
13
Nepal
13
Nigeria
12
Ghana
12
Bangladesh
10
Africa
9
Philippines
8
Tanzania
8
Western and Central Europe
8
Zimbabwe
7
Zambia
7
Syria
7
Myanmar / Burma
7
West and Central Africa
7
Latin America and the Carribbean
7
Rwanda
6
Indonesia
6
Namibia
6
Malawi
5
Ukraine
5
Botswana
5
Mozambique
4
East and Southern Africa
4
South–East Asia Region
4
Asia
4
Eastern Europe
4
Pakistan
3
Thailand
3
Eswatini/ Swaziland
3
Lesotho
3
Middle East and North Africa
3
Liberia
2
Senegal
2
Haiti
2
Jordan
2
Afghanistan
2
Cambodia
2
Eastern Europe and Central Asia
2
Venezuela
2
Laos
2
Burkina Faso
1
Congo, Democratic Republic of
1
Mali
1
USA
1
Saudi Arabia
1
South Sudan
1
Germany
1
Lebanon
1
Egypt
1
China
1
Sudan
1
Benin
1
Central African Republic
1
Brazil
1
Colombia
1
Sri Lanka
1
Chile
1
Western Pacific Region
1
Albania
1
Tajikistan
1
Lithuania
1
Moldova
1
Iran
1
Kyrgyzstan
1
Vietnam
1
North America
1
Turkmenistan
1
Denmark
1
Maldives
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
238
Clinical Guidelines
36
Public Health
26
Key Resources
20
Pharmacy & Technologies
15
Women & Child Health
8
Capacity Building
4
Annual Report MEDBOX
2
Toolboxes
AMR
112
Pharmacy
61
COVID-19
54
HIV
30
Mental Health
30
Rapid Response
24
Planetary Health
22
Global Health Education
20
NCDs
19
TB
17
NTDs
14
Health Financing Toolbox
12
Ebola
10
Conflict
8
Caregiver
7
Specific Hazards
6
Disability
3
Refugee
3
Polio
2
Zika
2
Cholera
1
Natural Hazards
1
Health Financing
1
22 Sept. 2021
The rapid development of effective Covid-19 vaccines in 2020 gave hope to the world in the darkest days of the deadly pandemic. However, the vaccine roll-out has been massively skewed towards wealthy nations. While rich states have hoarded vaccines, companies have also played a decisi
...
This guideline is intended to provide requirements to applicants wishing to submit
applications for registration of medicines in Botswana.
The growing challenges for people in low and middle-income countries to access new medicines.
Analysis 58
Drug Advisory Board
PHARMA’S RESPONSE TO THE COVID-19 VACCINES CRISIS. Update Feb., 14, 2022. In September 2021, Amnesty International published A Double Dose of Inequality, which assessed the extent to which the pharmaceutical
...
Access to NCD medicines: emergent issues during the COVID-19 pandemic and key structural factors
recommended
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health sys
...
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health sys
...
Examination of the business behavior of Boehringer Ingelheim, Bayer and Baxter in India
Medicines and Allied Substances [No. 3 of 2013 47 | An Act to continue the existence of the Pharmaceutical Regulatory Authority and re-name it as the Zambia Medicines Regulatory Authority; provide for the functions and powers of the Authority; provi
...
This guidance should be followed if an unlicensed medicine is prepared in
a registered pharmacy. The preparation of an unlicensed medicine (for
example unlicensed methadone, or menthol in aqueous cream) in a pharmacy is called ‘extemporaneous preparation’.
The guidance should be read alon
...
The Antimicrobial Resistance Benchmark has evaluated for the second time how the most important players in the antibiotic market are addressing the rise of resistance and the global need for appropriate access to antibiotics. Although we can see progress — it’s hanging by a thread.
We have reac
...
Spread of resistance to antimicrobial agents (AMR) does not know national borders and has reached dimensions, which require immediate actions at the national, regional and global levels.
Antibiotic resistance is a natural biological response to improper use of antimicrobial agents (AMA); increasing
...
This report provides an update on the key facets of HIV treatment access, including the latest HIV treatment guidelines from World Health Organization (WHO), an overview on pricing for first-line, second-line, and salvage regimens, and a summary of the opportunities for – and threats to – expand
...
2nd edition - Published in 2003, the first WHO/HAI medicine prices manual Medicine Prices – A
New Approach to Measurement Draft for field-testing provides a draft methodology and tools to conduct national medicine prices and availability surveys. This second edition of the survey manual has been
...
The Virtual cGMP Training Marathon for Vaccine Manufacturing: Principles into Practice took place from 12 Sep to 10 Oct 2023 to continue to provide manufacturers & regulators with a comprehensive array of topics to build understanding of current WHO & international GMP standards, technological advan
...
The 2018 Access to Medicine Index finds that the pharmaceutical industry continues to mature in its approach to access to medicine, with models for good practice in areas such as access planning and
...
